T1 may promote immune tolerance and regulation, allowing the body to better encourage proper immune response rather than broadly suppressing the immune system
clinical studies on the MindBody GLP-1 System include: Over 200% average increase in GLP-1 over 12 weeks Average weight loss of 11 pounds within 12 weeks, with some participants losing up to 25 pounds , Up to 9% decrease in total body fat percentage , Up to 24% decrease in visceral fat , Up to 9% decrease in subcutaneous fat , Up to 6% increase in skeletal muscle 100% of weight lost was from fat, not muscle , In addition to these physical results, participants reported notable changes in their relationship with food: 95% reported decreased sugar cravings 89% reported decreased fast-food cravings 86% reported decreased cravings for salt and soda 85% now eat for health instead of emotions 81% reported increased ability to resist snacking 89% ate less at meals 86% reported feeling less hungry Additionally, LifeVantage completed an independent 12-week human clinical trial of the international formula, known as the MB System, affirming the Companys commitment to science-backed innovation across global markets
The sequencing and bioinformatic analysis was performed by the Genome Technology Access Center at the McDonnell Genome Institute
doi: 10.1530/REP-08-0091 15 Outeirio-IglesiasVRoman-PrezMGonzlez-MatasLCVigoEMalloF
